ES2073868T3 - Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo. - Google Patents

Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo.

Info

Publication number
ES2073868T3
ES2073868T3 ES92304517T ES92304517T ES2073868T3 ES 2073868 T3 ES2073868 T3 ES 2073868T3 ES 92304517 T ES92304517 T ES 92304517T ES 92304517 T ES92304517 T ES 92304517T ES 2073868 T3 ES2073868 T3 ES 2073868T3
Authority
ES
Spain
Prior art keywords
pleuronumonia
prophylactic
pig
therapeutic composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92304517T
Other languages
English (en)
Spanish (es)
Inventor
Masaaki Okada
Shigeyoshi Ura
Satoru Nakano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2073868T3 publication Critical patent/ES2073868T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES92304517T 1991-06-04 1992-05-19 Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo. Expired - Lifetime ES2073868T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23072291 1991-06-04

Publications (1)

Publication Number Publication Date
ES2073868T3 true ES2073868T3 (es) 1995-08-16

Family

ID=16912285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92304517T Expired - Lifetime ES2073868T3 (es) 1991-06-04 1992-05-19 Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo.

Country Status (9)

Country Link
US (1) US5264417A (forum.php)
EP (1) EP0517394B1 (forum.php)
JP (1) JPH0655671B2 (forum.php)
AT (1) ATE124217T1 (forum.php)
CA (1) CA2070366C (forum.php)
DE (1) DE69203164T2 (forum.php)
DK (1) DK0517394T3 (forum.php)
ES (1) ES2073868T3 (forum.php)
TW (1) TW197946B (forum.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525722A (en) * 1993-01-28 1996-06-11 Fujisawa Pharmaceutical Co., Ltd. Process for producing biocozamycin benzoate
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
CA2723989C (en) * 2008-05-13 2017-04-25 Astrazeneca Ab Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline
IL294514A (en) * 2008-12-18 2022-09-01 Novartis Ag Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4829158B1 (forum.php) * 1970-10-12 1973-09-07
JPS5017996B2 (forum.php) * 1971-10-01 1975-06-25
GB1568961A (en) * 1975-10-20 1980-06-11 Fujisawa Pharmaceutical Co Bicyclomycin derivatives
LU75516A1 (forum.php) * 1976-08-02 1978-02-13
JPS5452731A (en) * 1977-09-14 1979-04-25 Fujisawa Pharmaceut Co Ltd Animal growth accelerator

Also Published As

Publication number Publication date
EP0517394B1 (en) 1995-06-28
TW197946B (forum.php) 1993-01-11
ATE124217T1 (de) 1995-07-15
EP0517394A1 (en) 1992-12-09
JPH05148144A (ja) 1993-06-15
US5264417A (en) 1993-11-23
CA2070366C (en) 1997-01-14
DE69203164D1 (de) 1995-08-03
CA2070366A1 (en) 1992-12-05
JPH0655671B2 (ja) 1994-07-27
DK0517394T3 (da) 1995-08-28
DE69203164T2 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
FI905983A0 (fi) Aminosyraderivat.
TW268942B (forum.php)
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
PL326024A1 (en) Novel derivatives of cyclodepsipeptidic substance pf1022
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
FI923664A0 (fi) Piperidinderivat.
ES2073868T3 (es) Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo.
EA200001029A1 (ru) Производные гигромицина
ES2062860T3 (es) Composicion farmaceutica para la mejoria de la disuria.
FI923662A0 (fi) Terapeutiska medel.
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
ATE197950T1 (de) Guanidylmethyl cyclohexancarbonsäure ester derivate
HUT70410A (en) Ketorolac derivative with considerably reduced gastro-intestinal irritation and ulceration
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517394

Country of ref document: ES